Bharat Biotech ramps up Covaxin production capacity

Credit: IndiaTimes- Published on April 20, 2021
To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its Covid-19 vaccine, Covaxin, to 700 million doses per annum, the vaccine maker said on Tuesday.

You are here

Related videos from verified sources

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin 01:14
Credit: ANI - Published on April 16, 2021 

Related news from verified sources

Bharat Biotech, the developer of indigenous Covid-19 vaccine Covaxin, on Tuesday said it has scaled up its manufacturing capacities of Covaxin to 700 million...
on April 20, 2021 • IndiaTimes

The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and...
on April 17, 2021 • IndiaTimes

You might like